BridgeMD
New treatment option for Multiple Myeloma (MM)
Official title Moving Forward With Myeloma: A Lifestyle Intervention for Individuals With Multiple Myeloma
ClinicalTrials.gov ID: NCT07236502
What this study is testing
- What it's testing
- The purpose of this project is to evaluate the impact of a 16-week lifestyle program that promotes changes in eating and exercise patterns. The main questions the study will answer are: Do improvements in eating and exercise patterns lead to improved physical function, quality of life and blood biomarkers of biologial aging among individuals with multiple myeloma?
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Adult (≥ 18 years)
- Diagnosed with MM at least one year prior to study enrollment
- Has access to a cell phone
- Be deemed "clinically stable" by their physician guided by the following:
- no near-term changes in planned myeloma-directed therapy anticipated. (e.g., patient who is 3 months from autologous stem cell transplant just...
You likely can't join if
- Individuals with \<6 months of life anticipated, coexistent amyloidosis, and/or receiving appetite stimulants will not be approached
- Fully adherent to the ACS nutrition and physical activity guidelines
- Currently pregnant or lactating, or anticipating pregnancy
- On another treatment clinical trial that precludes co-enrollment
- Psychiatric or other clinical conditions that preclude study compliance
- Other important medical or safety considerations at the discretion of the investigator(s) and/or approving clinician
See the full eligibility criteria
- Adult (≥ 18 years)
- Diagnosed with MM at least one year prior to study enrollment
- Has access to a cell phone
- Be deemed "clinically stable" by their physician guided by the following:
- no near-term changes in planned myeloma-directed therapy anticipated. (e.g., patient who is 3 months from autologous stem cell transplant just starting on maintenance lenalidomide is eligible since maintenance is...
- no new significant myeloma symptoms (e.g., fractures) meriting changes in anti-neoplastic therapies; AND
- stable performance status (ECOG 0-2)
- No reports of severe pain \> Grade 3 [defined by the NCI CTCAE as tumor, neurologic, bone, or other pain interfering with self-care ADLs (bathing, dressing, toileting, continence, feeding)].
- Able to participate in moderate PA and strength training per clinician approval and confirmed by participant
- Able to understand and willing to sign a written informed consent document
- English proficient for reading and writing
- Individuals with \<6 months of life anticipated, coexistent amyloidosis, and/or receiving appetite stimulants will not be approached
- Fully adherent to the ACS nutrition and physical activity guidelines
- Currently pregnant or lactating, or anticipating pregnancy
- On another treatment clinical trial that precludes co-enrollment
- Psychiatric or other clinical conditions that preclude study compliance
- Other important medical or safety considerations at the discretion of the investigator(s) and/or approving clinician
The study team makes the final eligibility decision.
Where it's taking place
- Maywood, Illinois, United States
- Milwaukee, Wisconsin, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Maywood, Illinois, United States; Milwaukee, Wisconsin, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.